Enveric Biosciences, Inc.
$1.37
+0.00 (+0.00%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -4.2%
- 3 Months
- -40.4%
- YTD
- -62.3%
- 1 Year
- -92.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 175.4%
- Largest decline max drawdown, since Aug 2025
- -92.7%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.70
Own ENVB?
See how ENVB contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.